BOTHELL, Wash. and COPENHAGEN, Denmark and BERKELEY, Calif. and TOKYO, Dec. 20, 2016 /PRNewswire/ — CMC Biologics, a global leader in clinical and commercial manufacturing of monoclonal antibodies, ...
CMC Biologics, a global leader in clinical and commercial manufacturing of therapeutic proteins, and River Vision Development Corporation (River Vision), a private company focused on ophthalmology, ...
Complete insights on biologic CMC requirements enable pharma, biotech and generics organizations to accelerate innovation by bringing life-saving medicines to ...
SOUTH SAN FRANCISCO, Calif. and SEATTLE, March 12 /PRNewswire/ -- Raven biotechnologies, inc., a privately held company focused on the discovery and development of monoclonal antibody therapeutics ...
According to Gustavo F. Mahler, Ph.D., Global Chief Operations Officer of CMC Biologics, "The expansion of the facility to include the 2,000L SUB will allow us to meet increasing demand for producing ...
CMC ICOS Biologics, a global leader in clinical and commercial manufacturing of therapeutic proteins, and Harpoon Therapeutics, an immuno-oncology company using a proprietary TriTAC technology ...
Discussion to Cover the Importance of Early-Stage CMC Testing in Enhancing Biologic Predictability, Scaling Up, and Accelerating Time to Market KAISERAUGST, Switzerland, April 22, 2025 /PRNewswire/ -- ...
Opportunities lie in enhancing regulatory compliance for biological drugs through specialized training. Courses focusing on CMC requirements, CTD quality modules, and molecule-specific strategies can ...
HanchorBio and WuXi Biologics collaborate to develop fusion proteins using the Fc-Based Designer Biologics platform, targeting oncology and autoimmune diseases. WuXi Biologics offers end-to-end ...
Complete insights on biologic CMC requirements enable pharma, biotech and generics organizations to accelerate innovation by bringing life-saving medicines to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results